Global Breast Biopsy

Breast Biopsy Comprehensive Study by Type (Core Needle Biopsy (CNB), Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy (FNAB)), Application (Hospitals, Clinics, Diagnostic Centers, Others), Biopsy Device (Biopsy Needles, Biopsy Tables, Guidance Systems, Localization Wires, Others (Markers, Punches, Sutures)), Tests (Physical Examination, Ultrasound, Mammogram, MRI Scan) Players and Region - Global Market Outlook to 2026

Breast Biopsy Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Breast Biopsy Market Overview:
A breast biopsy is the medical process for diagnosing and monitoring breast-related issues, in this sample of tissue is taken and tested in the laboratory to get the results. The biopsy of the breast makes it easier to evaluate any kind of lump or cancerous part in the breast and helps in timely treatment. The core needle biopsy (CNB), vacuum-assisted biopsy (VAB), and fine-needle aspiration biopsy (FNAB) are used. Several tests like physical examination, ultrasound, mammogram, and MRI scan are done for breast biopsy.

Growth Drivers
  • Rising Prevalence of Breast Cancer
  • Growing Number of Other Breast Related Diseases in People

Roadblocks
  • Risk of Infection and Other Possible Side Effects Associated with the Breast Biopsy

Opportunities
  • Increasing Awareness about the Regular Health Checkup will Boost the Breast Biopsy Market

Challenges
  • High Cost Involved in the Breast Biopsy Technology


Competitive Landscape:

Some of the key players profiled in the report are Johnson & Johnson (United States), Becton, Dickinson, and Company (United States), Hologic, Inc. (United States), Devicor Medical Products, Inc., (Mammotome) (United States), Argon Medical Devices, Inc. (United States), GE Healthcare (United States), ANGLE plc (United Kingdom) and NeoDynamics AB (Sweden). Considering Market by Biopsy Device, the sub-segment i.e. Biopsy Needles will boost the Breast Biopsy market. Considering Market by Tests, the sub-segment i.e. Physical Examination will boost the Breast Biopsy market.

Latest Market Insights:
On 2nd December 2019, GE Healthcare has launched the new Serena Bright, which is claimed to be the healthcare industry’s first contrast-enhanced mammography solution for biopsy. The company has developed a contrast-enhanced mammography solution to help clinicians better treat patients with breast cancer. Serena Bright enables one to conduct breast biopsy exams with the same mammography equipment and in the same room as the screening or diagnostic mammogram according to the company, the contrast-enhanced biopsy was performed with breast MR for lesions not seen on mammography or ultrasound, which was time-consuming, uncomfortable and costly for patients.

On 28th August 2020, Hologic, Inc. an innovative medical technology company primarily focused on improving women’s health, announced improvements to the Brevera Breast Biopsy System with CorLumina Imaging Technology, the world’s first and only breast biopsy solution to combine vacuum-assisted tissue acquisition, real-time imaging verification and advanced post-biopsy handling in one, integrated system.

What Can be Explored with the Breast Biopsy Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Breast Biopsy Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Breast Biopsy
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Breast Biopsy market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Breast Biopsy market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Breast Biopsy Device Manufacturers, Breast Biopsy Industry Association, Hospitals and Diagnostic Centers, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Core Needle Biopsy (CNB)
  • Vacuum-Assisted Biopsy (VAB)
  • Fine Needle Aspiration Biopsy (FNAB)
By Application
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others
By Biopsy Device
  • Biopsy Needles
  • Biopsy Tables
  • Guidance Systems
  • Localization Wires
  • Others (Markers, Punches, Sutures)

By Tests
  • Physical Examination
  • Ultrasound
  • Mammogram
  • MRI Scan

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Breast Cancer
      • 3.2.2. Growing Number of Other Breast Related Diseases in People
    • 3.3. Market Challenges
      • 3.3.1. High Cost Involved in the Breast Biopsy Technology
    • 3.4. Market Trends
      • 3.4.1. Increasing Use of Core Needle Biopsy (CNB) in the Breast Biopsy
      • 3.4.2. Technological Advancements in the Breast Biopsy
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Breast Biopsy, by Type, Application, Biopsy Device, Tests and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Breast Biopsy (Value)
      • 5.2.1. Global Breast Biopsy by: Type (Value)
        • 5.2.1.1. Core Needle Biopsy (CNB)
        • 5.2.1.2. Vacuum-Assisted Biopsy (VAB)
        • 5.2.1.3. Fine Needle Aspiration Biopsy (FNAB)
      • 5.2.2. Global Breast Biopsy by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Diagnostic Centers
        • 5.2.2.4. Others
      • 5.2.3. Global Breast Biopsy by: Biopsy Device (Value)
        • 5.2.3.1. Biopsy Needles
        • 5.2.3.2. Biopsy Tables
        • 5.2.3.3. Guidance Systems
        • 5.2.3.4. Localization Wires
        • 5.2.3.5. Others (Markers, Punches, Sutures)
      • 5.2.4. Global Breast Biopsy by: Tests (Value)
        • 5.2.4.1. Physical Examination
        • 5.2.4.2. Ultrasound
        • 5.2.4.3. Mammogram
        • 5.2.4.4. MRI Scan
      • 5.2.5. Global Breast Biopsy Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Breast Biopsy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson, and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hologic, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Devicor Medical Products, Inc., (Mammotome) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Argon Medical Devices, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GE Healthcare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ANGLE plc (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. NeoDynamics AB (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Breast Biopsy Sale, by Type, Application, Biopsy Device, Tests and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Breast Biopsy (Value)
      • 7.2.1. Global Breast Biopsy by: Type (Value)
        • 7.2.1.1. Core Needle Biopsy (CNB)
        • 7.2.1.2. Vacuum-Assisted Biopsy (VAB)
        • 7.2.1.3. Fine Needle Aspiration Biopsy (FNAB)
      • 7.2.2. Global Breast Biopsy by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Diagnostic Centers
        • 7.2.2.4. Others
      • 7.2.3. Global Breast Biopsy by: Biopsy Device (Value)
        • 7.2.3.1. Biopsy Needles
        • 7.2.3.2. Biopsy Tables
        • 7.2.3.3. Guidance Systems
        • 7.2.3.4. Localization Wires
        • 7.2.3.5. Others (Markers, Punches, Sutures)
      • 7.2.4. Global Breast Biopsy by: Tests (Value)
        • 7.2.4.1. Physical Examination
        • 7.2.4.2. Ultrasound
        • 7.2.4.3. Mammogram
        • 7.2.4.4. MRI Scan
      • 7.2.5. Global Breast Biopsy Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Breast Biopsy: by Type(USD Million)
  • Table 2. Breast Biopsy Core Needle Biopsy (CNB) , by Region USD Million (2015-2020)
  • Table 3. Breast Biopsy Vacuum-Assisted Biopsy (VAB) , by Region USD Million (2015-2020)
  • Table 4. Breast Biopsy Fine Needle Aspiration Biopsy (FNAB) , by Region USD Million (2015-2020)
  • Table 5. Breast Biopsy: by Application(USD Million)
  • Table 6. Breast Biopsy Hospitals , by Region USD Million (2015-2020)
  • Table 7. Breast Biopsy Clinics , by Region USD Million (2015-2020)
  • Table 8. Breast Biopsy Diagnostic Centers , by Region USD Million (2015-2020)
  • Table 9. Breast Biopsy Others , by Region USD Million (2015-2020)
  • Table 10. Breast Biopsy: by Biopsy Device(USD Million)
  • Table 11. Breast Biopsy Biopsy Needles , by Region USD Million (2015-2020)
  • Table 12. Breast Biopsy Biopsy Tables , by Region USD Million (2015-2020)
  • Table 13. Breast Biopsy Guidance Systems , by Region USD Million (2015-2020)
  • Table 14. Breast Biopsy Localization Wires , by Region USD Million (2015-2020)
  • Table 15. Breast Biopsy Others (Markers, Punches, Sutures) , by Region USD Million (2015-2020)
  • Table 16. Breast Biopsy: by Tests(USD Million)
  • Table 17. Breast Biopsy Physical Examination , by Region USD Million (2015-2020)
  • Table 18. Breast Biopsy Ultrasound , by Region USD Million (2015-2020)
  • Table 19. Breast Biopsy Mammogram , by Region USD Million (2015-2020)
  • Table 20. Breast Biopsy MRI Scan , by Region USD Million (2015-2020)
  • Table 21. South America Breast Biopsy, by Country USD Million (2015-2020)
  • Table 22. South America Breast Biopsy, by Type USD Million (2015-2020)
  • Table 23. South America Breast Biopsy, by Application USD Million (2015-2020)
  • Table 24. South America Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 25. South America Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 26. Brazil Breast Biopsy, by Type USD Million (2015-2020)
  • Table 27. Brazil Breast Biopsy, by Application USD Million (2015-2020)
  • Table 28. Brazil Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 29. Brazil Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 30. Argentina Breast Biopsy, by Type USD Million (2015-2020)
  • Table 31. Argentina Breast Biopsy, by Application USD Million (2015-2020)
  • Table 32. Argentina Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 33. Argentina Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 34. Rest of South America Breast Biopsy, by Type USD Million (2015-2020)
  • Table 35. Rest of South America Breast Biopsy, by Application USD Million (2015-2020)
  • Table 36. Rest of South America Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 37. Rest of South America Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 38. Asia Pacific Breast Biopsy, by Country USD Million (2015-2020)
  • Table 39. Asia Pacific Breast Biopsy, by Type USD Million (2015-2020)
  • Table 40. Asia Pacific Breast Biopsy, by Application USD Million (2015-2020)
  • Table 41. Asia Pacific Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 42. Asia Pacific Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 43. China Breast Biopsy, by Type USD Million (2015-2020)
  • Table 44. China Breast Biopsy, by Application USD Million (2015-2020)
  • Table 45. China Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 46. China Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 47. Japan Breast Biopsy, by Type USD Million (2015-2020)
  • Table 48. Japan Breast Biopsy, by Application USD Million (2015-2020)
  • Table 49. Japan Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 50. Japan Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 51. India Breast Biopsy, by Type USD Million (2015-2020)
  • Table 52. India Breast Biopsy, by Application USD Million (2015-2020)
  • Table 53. India Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 54. India Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 55. South Korea Breast Biopsy, by Type USD Million (2015-2020)
  • Table 56. South Korea Breast Biopsy, by Application USD Million (2015-2020)
  • Table 57. South Korea Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 58. South Korea Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 59. Taiwan Breast Biopsy, by Type USD Million (2015-2020)
  • Table 60. Taiwan Breast Biopsy, by Application USD Million (2015-2020)
  • Table 61. Taiwan Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 62. Taiwan Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 63. Australia Breast Biopsy, by Type USD Million (2015-2020)
  • Table 64. Australia Breast Biopsy, by Application USD Million (2015-2020)
  • Table 65. Australia Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 66. Australia Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Breast Biopsy, by Type USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Breast Biopsy, by Application USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 71. Europe Breast Biopsy, by Country USD Million (2015-2020)
  • Table 72. Europe Breast Biopsy, by Type USD Million (2015-2020)
  • Table 73. Europe Breast Biopsy, by Application USD Million (2015-2020)
  • Table 74. Europe Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 75. Europe Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 76. Germany Breast Biopsy, by Type USD Million (2015-2020)
  • Table 77. Germany Breast Biopsy, by Application USD Million (2015-2020)
  • Table 78. Germany Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 79. Germany Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 80. France Breast Biopsy, by Type USD Million (2015-2020)
  • Table 81. France Breast Biopsy, by Application USD Million (2015-2020)
  • Table 82. France Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 83. France Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 84. Italy Breast Biopsy, by Type USD Million (2015-2020)
  • Table 85. Italy Breast Biopsy, by Application USD Million (2015-2020)
  • Table 86. Italy Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 87. Italy Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 88. United Kingdom Breast Biopsy, by Type USD Million (2015-2020)
  • Table 89. United Kingdom Breast Biopsy, by Application USD Million (2015-2020)
  • Table 90. United Kingdom Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 91. United Kingdom Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 92. Netherlands Breast Biopsy, by Type USD Million (2015-2020)
  • Table 93. Netherlands Breast Biopsy, by Application USD Million (2015-2020)
  • Table 94. Netherlands Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 95. Netherlands Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 96. Rest of Europe Breast Biopsy, by Type USD Million (2015-2020)
  • Table 97. Rest of Europe Breast Biopsy, by Application USD Million (2015-2020)
  • Table 98. Rest of Europe Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 99. Rest of Europe Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 100. MEA Breast Biopsy, by Country USD Million (2015-2020)
  • Table 101. MEA Breast Biopsy, by Type USD Million (2015-2020)
  • Table 102. MEA Breast Biopsy, by Application USD Million (2015-2020)
  • Table 103. MEA Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 104. MEA Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 105. Middle East Breast Biopsy, by Type USD Million (2015-2020)
  • Table 106. Middle East Breast Biopsy, by Application USD Million (2015-2020)
  • Table 107. Middle East Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 108. Middle East Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 109. Africa Breast Biopsy, by Type USD Million (2015-2020)
  • Table 110. Africa Breast Biopsy, by Application USD Million (2015-2020)
  • Table 111. Africa Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 112. Africa Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 113. North America Breast Biopsy, by Country USD Million (2015-2020)
  • Table 114. North America Breast Biopsy, by Type USD Million (2015-2020)
  • Table 115. North America Breast Biopsy, by Application USD Million (2015-2020)
  • Table 116. North America Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 117. North America Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 118. United States Breast Biopsy, by Type USD Million (2015-2020)
  • Table 119. United States Breast Biopsy, by Application USD Million (2015-2020)
  • Table 120. United States Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 121. United States Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 122. Canada Breast Biopsy, by Type USD Million (2015-2020)
  • Table 123. Canada Breast Biopsy, by Application USD Million (2015-2020)
  • Table 124. Canada Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 125. Canada Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 126. Mexico Breast Biopsy, by Type USD Million (2015-2020)
  • Table 127. Mexico Breast Biopsy, by Application USD Million (2015-2020)
  • Table 128. Mexico Breast Biopsy, by Biopsy Device USD Million (2015-2020)
  • Table 129. Mexico Breast Biopsy, by Tests USD Million (2015-2020)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Breast Biopsy: by Type(USD Million)
  • Table 139. Breast Biopsy Core Needle Biopsy (CNB) , by Region USD Million (2021-2026)
  • Table 140. Breast Biopsy Vacuum-Assisted Biopsy (VAB) , by Region USD Million (2021-2026)
  • Table 141. Breast Biopsy Fine Needle Aspiration Biopsy (FNAB) , by Region USD Million (2021-2026)
  • Table 142. Breast Biopsy: by Application(USD Million)
  • Table 143. Breast Biopsy Hospitals , by Region USD Million (2021-2026)
  • Table 144. Breast Biopsy Clinics , by Region USD Million (2021-2026)
  • Table 145. Breast Biopsy Diagnostic Centers , by Region USD Million (2021-2026)
  • Table 146. Breast Biopsy Others , by Region USD Million (2021-2026)
  • Table 147. Breast Biopsy: by Biopsy Device(USD Million)
  • Table 148. Breast Biopsy Biopsy Needles , by Region USD Million (2021-2026)
  • Table 149. Breast Biopsy Biopsy Tables , by Region USD Million (2021-2026)
  • Table 150. Breast Biopsy Guidance Systems , by Region USD Million (2021-2026)
  • Table 151. Breast Biopsy Localization Wires , by Region USD Million (2021-2026)
  • Table 152. Breast Biopsy Others (Markers, Punches, Sutures) , by Region USD Million (2021-2026)
  • Table 153. Breast Biopsy: by Tests(USD Million)
  • Table 154. Breast Biopsy Physical Examination , by Region USD Million (2021-2026)
  • Table 155. Breast Biopsy Ultrasound , by Region USD Million (2021-2026)
  • Table 156. Breast Biopsy Mammogram , by Region USD Million (2021-2026)
  • Table 157. Breast Biopsy MRI Scan , by Region USD Million (2021-2026)
  • Table 158. South America Breast Biopsy, by Country USD Million (2021-2026)
  • Table 159. South America Breast Biopsy, by Type USD Million (2021-2026)
  • Table 160. South America Breast Biopsy, by Application USD Million (2021-2026)
  • Table 161. South America Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 162. South America Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 163. Brazil Breast Biopsy, by Type USD Million (2021-2026)
  • Table 164. Brazil Breast Biopsy, by Application USD Million (2021-2026)
  • Table 165. Brazil Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 166. Brazil Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 167. Argentina Breast Biopsy, by Type USD Million (2021-2026)
  • Table 168. Argentina Breast Biopsy, by Application USD Million (2021-2026)
  • Table 169. Argentina Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 170. Argentina Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 171. Rest of South America Breast Biopsy, by Type USD Million (2021-2026)
  • Table 172. Rest of South America Breast Biopsy, by Application USD Million (2021-2026)
  • Table 173. Rest of South America Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 174. Rest of South America Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 175. Asia Pacific Breast Biopsy, by Country USD Million (2021-2026)
  • Table 176. Asia Pacific Breast Biopsy, by Type USD Million (2021-2026)
  • Table 177. Asia Pacific Breast Biopsy, by Application USD Million (2021-2026)
  • Table 178. Asia Pacific Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 179. Asia Pacific Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 180. China Breast Biopsy, by Type USD Million (2021-2026)
  • Table 181. China Breast Biopsy, by Application USD Million (2021-2026)
  • Table 182. China Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 183. China Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 184. Japan Breast Biopsy, by Type USD Million (2021-2026)
  • Table 185. Japan Breast Biopsy, by Application USD Million (2021-2026)
  • Table 186. Japan Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 187. Japan Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 188. India Breast Biopsy, by Type USD Million (2021-2026)
  • Table 189. India Breast Biopsy, by Application USD Million (2021-2026)
  • Table 190. India Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 191. India Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 192. South Korea Breast Biopsy, by Type USD Million (2021-2026)
  • Table 193. South Korea Breast Biopsy, by Application USD Million (2021-2026)
  • Table 194. South Korea Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 195. South Korea Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 196. Taiwan Breast Biopsy, by Type USD Million (2021-2026)
  • Table 197. Taiwan Breast Biopsy, by Application USD Million (2021-2026)
  • Table 198. Taiwan Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 199. Taiwan Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 200. Australia Breast Biopsy, by Type USD Million (2021-2026)
  • Table 201. Australia Breast Biopsy, by Application USD Million (2021-2026)
  • Table 202. Australia Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 203. Australia Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 204. Rest of Asia-Pacific Breast Biopsy, by Type USD Million (2021-2026)
  • Table 205. Rest of Asia-Pacific Breast Biopsy, by Application USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 207. Rest of Asia-Pacific Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 208. Europe Breast Biopsy, by Country USD Million (2021-2026)
  • Table 209. Europe Breast Biopsy, by Type USD Million (2021-2026)
  • Table 210. Europe Breast Biopsy, by Application USD Million (2021-2026)
  • Table 211. Europe Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 212. Europe Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 213. Germany Breast Biopsy, by Type USD Million (2021-2026)
  • Table 214. Germany Breast Biopsy, by Application USD Million (2021-2026)
  • Table 215. Germany Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 216. Germany Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 217. France Breast Biopsy, by Type USD Million (2021-2026)
  • Table 218. France Breast Biopsy, by Application USD Million (2021-2026)
  • Table 219. France Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 220. France Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 221. Italy Breast Biopsy, by Type USD Million (2021-2026)
  • Table 222. Italy Breast Biopsy, by Application USD Million (2021-2026)
  • Table 223. Italy Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 224. Italy Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 225. United Kingdom Breast Biopsy, by Type USD Million (2021-2026)
  • Table 226. United Kingdom Breast Biopsy, by Application USD Million (2021-2026)
  • Table 227. United Kingdom Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 228. United Kingdom Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 229. Netherlands Breast Biopsy, by Type USD Million (2021-2026)
  • Table 230. Netherlands Breast Biopsy, by Application USD Million (2021-2026)
  • Table 231. Netherlands Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 232. Netherlands Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 233. Rest of Europe Breast Biopsy, by Type USD Million (2021-2026)
  • Table 234. Rest of Europe Breast Biopsy, by Application USD Million (2021-2026)
  • Table 235. Rest of Europe Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 236. Rest of Europe Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 237. MEA Breast Biopsy, by Country USD Million (2021-2026)
  • Table 238. MEA Breast Biopsy, by Type USD Million (2021-2026)
  • Table 239. MEA Breast Biopsy, by Application USD Million (2021-2026)
  • Table 240. MEA Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 241. MEA Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 242. Middle East Breast Biopsy, by Type USD Million (2021-2026)
  • Table 243. Middle East Breast Biopsy, by Application USD Million (2021-2026)
  • Table 244. Middle East Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 245. Middle East Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 246. Africa Breast Biopsy, by Type USD Million (2021-2026)
  • Table 247. Africa Breast Biopsy, by Application USD Million (2021-2026)
  • Table 248. Africa Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 249. Africa Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 250. North America Breast Biopsy, by Country USD Million (2021-2026)
  • Table 251. North America Breast Biopsy, by Type USD Million (2021-2026)
  • Table 252. North America Breast Biopsy, by Application USD Million (2021-2026)
  • Table 253. North America Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 254. North America Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 255. United States Breast Biopsy, by Type USD Million (2021-2026)
  • Table 256. United States Breast Biopsy, by Application USD Million (2021-2026)
  • Table 257. United States Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 258. United States Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 259. Canada Breast Biopsy, by Type USD Million (2021-2026)
  • Table 260. Canada Breast Biopsy, by Application USD Million (2021-2026)
  • Table 261. Canada Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 262. Canada Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 263. Mexico Breast Biopsy, by Type USD Million (2021-2026)
  • Table 264. Mexico Breast Biopsy, by Application USD Million (2021-2026)
  • Table 265. Mexico Breast Biopsy, by Biopsy Device USD Million (2021-2026)
  • Table 266. Mexico Breast Biopsy, by Tests USD Million (2021-2026)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Breast Biopsy: by Type USD Million (2015-2020)
  • Figure 5. Global Breast Biopsy: by Application USD Million (2015-2020)
  • Figure 6. Global Breast Biopsy: by Biopsy Device USD Million (2015-2020)
  • Figure 7. Global Breast Biopsy: by Tests USD Million (2015-2020)
  • Figure 8. South America Breast Biopsy Share (%), by Country
  • Figure 9. Asia Pacific Breast Biopsy Share (%), by Country
  • Figure 10. Europe Breast Biopsy Share (%), by Country
  • Figure 11. MEA Breast Biopsy Share (%), by Country
  • Figure 12. North America Breast Biopsy Share (%), by Country
  • Figure 13. Global Breast Biopsy share by Players 2020 (%)
  • Figure 14. Global Breast Biopsy share by Players (Top 3) 2020(%)
  • Figure 15. Global Breast Biopsy share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 18. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 19. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 20. Becton, Dickinson, and Company (United States) Revenue: by Geography 2020
  • Figure 21. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Hologic, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Devicor Medical Products, Inc., (Mammotome) (United States) Revenue, Net Income and Gross profit
  • Figure 24. Devicor Medical Products, Inc., (Mammotome) (United States) Revenue: by Geography 2020
  • Figure 25. Argon Medical Devices, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Argon Medical Devices, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 28. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 29. ANGLE plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. ANGLE plc (United Kingdom) Revenue: by Geography 2020
  • Figure 31. NeoDynamics AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 32. NeoDynamics AB (Sweden) Revenue: by Geography 2020
  • Figure 33. Global Breast Biopsy: by Type USD Million (2021-2026)
  • Figure 34. Global Breast Biopsy: by Application USD Million (2021-2026)
  • Figure 35. Global Breast Biopsy: by Biopsy Device USD Million (2021-2026)
  • Figure 36. Global Breast Biopsy: by Tests USD Million (2021-2026)
  • Figure 37. South America Breast Biopsy Share (%), by Country
  • Figure 38. Asia Pacific Breast Biopsy Share (%), by Country
  • Figure 39. Europe Breast Biopsy Share (%), by Country
  • Figure 40. MEA Breast Biopsy Share (%), by Country
  • Figure 41. North America Breast Biopsy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson (United States)
  • Becton, Dickinson, and Company (United States)
  • Hologic, Inc. (United States)
  • Devicor Medical Products, Inc., (Mammotome) (United States)
  • Argon Medical Devices, Inc. (United States)
  • GE Healthcare (United States)
  • ANGLE plc (United Kingdom)
  • NeoDynamics AB (Sweden)
Select User Access Type

Key Highlights of Report


Sep 2021 237 Pages 87 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Breast Biopsy Quantitative research analysis
Global Breast Biopsy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Breast Biopsy market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Breast Biopsy market are Johnson & Johnson (United States), Becton, Dickinson, and Company (United States), Hologic, Inc. (United States), Devicor Medical Products, Inc., (Mammotome) (United States), Argon Medical Devices, Inc. (United States), GE Healthcare (United States), ANGLE plc (United Kingdom) and NeoDynamics AB (Sweden), to name a few.
"Increasing Use of Core Needle Biopsy (CNB) in the Breast Biopsy " is seen as one of major influencing trends for Breast Biopsy Market during projected period 2020-2026.

Know More About Global Breast Biopsy Report?

Have a Query? Click Here

Other Related Reports

Antiretroviral Therapy Comprehensive Study by Route of Administration (Oral, Parenteral), Class (Nucleoside Reverse Transcriptase Inhibitors, HIV Protease Inhibitors, Non-nucleoside Reverse Transcrip...
$ 3650
CD Antigen Cancer Therapy Comprehensive Study by Type (Monoclonal Antibodies, Antibody-Drug-Conjugates, Tri-Functional & Bi-Specific T-Cell Engager Antibodies, Other), Application (Hospitals, Homecar...
$ 3750
Neuroprotection Comprehensive Study by Type (Free Radical Trapping Agents (Antioxidants), Glutamate Antagonists (Anti-Excitotoxic Agents), Apoptosis Inhibitors, Anti-inflammatory Agents, Neurotrophic...
$ 3750
Human Rabies Immunoglobulin Comprehensive Study by Side effects (Pain, Fever, Headache, Others), Rabies (Encephalitic, Paralytic), Immunoglobulin (IgG, IgM, IgA, IgD, IgE) Players and Region - Globa...
$ 3500
Flu Vaccine Comprehensive Study by Type (Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines, Live Attenuated Virus Vaccines), Application (For Children (6 months to 3 years), For Adults and...
$ 3450
Vascular Graft Comprehensive Study by Raw Material (Polyester, EPTFE, Polyurethane, Biosyntheti), Indication (EVAR (Abdominal Aneurysm Repair & Thoracic Aneurysm0, Peripheral Vascular Repair, Hemodia...
$ 3450